Updated Jul 16, 2026
Dandekar Atul has filed 4 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.49M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-01 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale | 7.5K | $28.02 | $210K |
| 2026-07-01 | MAZE | Maze Therapeutics, Inc. | M — Option exercise | 7.5K | $10.42 | $78K |
| 2026-06-02 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale | 7.5K | $26.34 | $198K |
| 2026-06-02 | MAZE | Maze Therapeutics, Inc. | M — Option exercise | 7.5K | $10.42 | $78K |
| 2026-05-06 | MAZE | Maze Therapeutics, Inc. | M — Option exercise | 6.0K | $10.42 | $62K |
| 2026-05-06 | MAZE | Maze Therapeutics, Inc. | M — Option exercise | 8.3K | $10.42 | $87K |
| 2026-05-01 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale | 7.5K | $25.37 | $190K |
| 2026-05-01 | MAZE | Maze Therapeutics, Inc. | M — Option exercise | 7.5K | $10.42 | $78K |
| 2026-04-01 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale [10b5-1] | 790 | $30.02 | $24K |
| 2026-04-01 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale [10b5-1] | 6.7K | $29.26 | $196K |
| 2026-04-01 | MAZE | Maze Therapeutics, Inc. | M — Option exercise [10b5-1] | 7.5K | $10.42 | $78K |
| 2026-03-03 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale [10b5-1] | 3.8K | $45.72 | $172K |
| 2026-03-03 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale [10b5-1] | 3.7K | $45.13 | $169K |
| 2026-03-03 | MAZE | Maze Therapeutics, Inc. | M — Option exercise [10b5-1] | 7.5K | $10.42 | $78K |
| 2026-02-02 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale [10b5-1] | 2.8K | $45.01 | $126K |
| 2026-02-02 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale [10b5-1] | 3.5K | $44.04 | $154K |
| 2026-02-02 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale [10b5-1] | 1.2K | $43.18 | $52K |
| 2026-02-02 | MAZE | Maze Therapeutics, Inc. | M — Option exercise [10b5-1] | 7.5K | $10.42 | $78K |
Dandekar Atul is a corporate insider — currently tracked as Insider of Maze Therapeutics, Inc. (MAZE). InsiderAlpha tracks every SEC Form 4 filing in real time.
4 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 10 open-market sales ($1.49M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Dandekar Atul profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.